Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 5, 2011, Pages 1193-1201

  Tapia Pérez, Jorge Humberto ^a   Kirches, Elmar ^a   Mawrin, Christian ^a   Firsching, Raimund ^a   Schneider, Thomas ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cytotoxicity; Glioblastoma; Statin; Thiazolidinediones

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ATORVASTATIN; CASPASE 3; FARNESYL DIPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE; ISOPRENOID; MEVINOLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PIOGLITAZONE; PRAVASTATIN; ROSIGLITAZONE; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CASPASE 3; CELL HYPOXIA; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; GLIOMA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RATS; THIAZOLIDINEDIONES;

EID: 79955559700     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1535-2     Document Type: Article

References (52)

1. B Agarwal S Bhendwal B Halmos SF Moss WG Ramey PR Holt 1999 Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells Clin Cancer Res 5 2223 10473109 1:CAS:528:DyaK1MXlvVOhu70%3D
2. P Amarenco J Bogousslavsky A Callahan 3rd LB Goldstein M Hennerici AE Rudolph, et al. 2006 Stroke prevention by aggressive reduction in cholesterol levels (SPARCL) investigators. High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 549 16899775 10.1056/NEJMoa061894 1:CAS:528:DC%2BD28XotVKgtb8%3D (Pubitemid 44202151)
3. Y Akasaki G Liu HH Matundan H Ng X Yuan Z Zeng KL Black JS Yu 2006 A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells J Biol Chem 281 6165 16319070 10.1074/jbc.M505266200 1:CAS:528:DC%2BD28XhvFOhtb0%3D (Pubitemid 43847546)
4. HL Bouterfa V Sattelmeyer S Czub D Vordermark K Roosen JC Tonn 2000 Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells Anticancer Res 20 2761 10953355 1:CAS:528:DC%2BD3cXlvFGjurc%3D
5. P Cafforio F Dammacco A Gernone F Silvetris 2005 Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells Carcinogenesis 26 883 15705602 10.1093/carcin/bgi036 1:CAS:528: DC%2BD2MXjsFOmsrg%3D (Pubitemid 41214316)
6. C Cemeus TT Zhao GM Barrett IA Lorimer J Dimitroulakos 2008 Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status J Neurooncol 90 9 18566746 10.1007/s11060-008-9627-0 1:CAS:528:DC%2BD1cXht1ejtLbM
7. DY Chan GG Chen WS Poon PC Liu 2008 Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis J Neurooncol 86 273 17928957 10.1007/s11060-007-9475-3 1:CAS:528:DC%2BD1cXivVKrtr4%3D
8. R Coras A Hölsken S Seufert J Hauke IY Eyüpoglu M Reichel, et al. 2007 The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion Mol Cancer Ther 6 1745 17541035 10.1158/1535-7163.MCT-06-0763 1:CAS:528:DC%2BD2sXmsFCru7w%3D (Pubitemid 46954051)
9. GD Demetri CD Fletcher E Mueller P Sarraf R Naujoks N Campbell BM Spiegelman S Singer 1999 Induction of solid tumor differentiation by the peroxisome proliferator activated receptor-γ ligand troglitazone in patients with liposarcoma Proc Natl Acad Sci USA 96 3951 10097144 10.1073/pnas.96.7.3951 1:CAS:528:DyaK1MXjslChsb0%3D (Pubitemid 29169017)
10. J Dimitroulakos S Thai GH Wasfy DW Hedley MD Minden LZ Penn 2000 Lovastatin induces a pronounced differentiation response in acute myeloid leukemias Leuk Lymphoma 40 167 11426618 10.3109/10428190009054894 1:CAS:528:DC%2BD3MXhtF2lsro%3D
11. J Dimitroulakos LY Ye M Benzaquen MJ Moore S Kamel-Reid MH Freedman H Yeger LZ Penn 2001 Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin induced apoptosis: therapeutic implications Clin Cancer Res 7 158 11205904 1:CAS:528:DC%2BD3MXht1WhtrY%3D
12. B Fletcher K Berra P Ades LT Braun LE Burke JL Durstine, et al. 2005 Managing abnormal blood lipids: a collaborative approach Circulation 112 3184 16286609 10.1161/CIRCULATIONAHA.105.169180 (Pubitemid 43113447)
13. D Gabryś A Dörfler A Yaromina F Hessel M Krause R Oertel M Baumann 2008 Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo Strahlenther Onkol 184 48 18188523 10.1007/s00066-008-1805-7
14. Gehring S, Tapia-Pérez JH, Kirches E, Firsching R, Keilhoff G, Schneider T, Mawrin C (2010) Cytotoxic effects of statins and thiazolidinediones on meningioma cells. J Neuro-oncol. doi: 10.1007/s11060-010-0351-1
15. J Gliemroth H Zulewski H Arnold AJ Terzis 2003 Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin Neurosurg Rev 26 117 12962298 10.1007/s10143-003-0258-9 (Pubitemid 36735735)
16. C Grommes GE Landreth M Sastre M Beck DL Feinstein AH Jacobs U Schlegel MT Heneka 2006 Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment Mol Pharmacol 70 1524 16887936 10.1124/mol.106.022194 1:CAS:528:DC%2BD28XhtFygsbnM
17. K Hindler CS Cleeland E Rivera CD Collard 2006 The role of statins in cancer therapy Oncologist 11 306 16549815 10.1634/theoncologist.11-3-306 1:CAS:528:DC%2BD28XhtFKlsbzL
18. SA Holstein HR Knapp GH Clamon DJ Murry RJ Hohl 2006 Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies Cancer Chemother Pharmacol 57 155 16133537 10.1007/s00280-005-0013-8 1:CAS:528:DC%2BD2MXhtlSjtb3L (Pubitemid 41779834)
19. R Jensen 2009 Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target J Neurooncol 92 317 19357959 10.1007/s11060-009-9827-2 1:CAS:528:DC%2BD1MXkt1yitL4%3D
20. Z Jiang X Zheng RA Lytle R Higashikubo KM Rich 2004 Lovastatin-induced up-regulation of the BH3-only protein, bim, and cell death in glioblastoma cells J Neurochem 89 168 15030401 10.1111/j.1471-4159.2004.02319.x 1:CAS:528:DC%2BD2cXjtValtrg%3D
21. KD Jones WT Couldwell DR Hinton Y Su S He L Anker RE Law 1994 Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells Biochem Biophys Res Commun 205 1681 7811252 10.1006/bbrc.1994.2861 1:CAS:528: DyaK2MXivV2rtbo%3D
22. DW Kang CH Choi JY Park SK Kang YK Kim 2008 Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells Neurochem Res 33 551 17940898 10.1007/s11064-007-9475-x 1:CAS:528:DC%2BD1cXhs1aiu7s%3D (Pubitemid 351230459)
23. OO Kanu A Mehta C Di N Lin K Bortoff DD Bigner H Yan DC Adamson 2009 Glioblastoma multiforme: a review of therapeutic targets Expert Opin Ther Targets 13 701 19409033 10.1517/14728220902942348 1:CAS:528:DC%2BD1MXmtFCisbY%3D
24. M Koyuturk M Ersoz N Altiok 2004 Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase Neurosci Lett 370 212 15488325 10.1016/j.neulet.2004.08.020 1:CAS:528: DC%2BD2cXos1emurg%3D (Pubitemid 39370881)
25. J Larner J Jane E Laws R Packer C Myers M Shaffrey 1998 A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme Am J Clin Oncol 21 579 9856659 10.1097/00000421-199812000-00010 1:STN:280: DyaK1M%2Fnt1Ckuw%3D%3D (Pubitemid 28558348)
26. T Lichtor RP Glick 2003 Cytokine immuno-gene therapy for treatment of brain tumors J Neuro Oncol 65 247 10.1023/B:NEON.0000003654.83272.4a (Pubitemid 37526817)
27. T Lichtor A Spagnolo RP Glick DL Feinstein 2008 PPAR-γ thiazolidinedione agonists and immunotherapy in the treatment of brain tumors PPAR Res 2008 547470 18509487
28. Y Maeshiba Y Kiyota K Yamashita Y Yoshimura M Motohashi S Tanayama 1997 Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys Arzneimittelforschung 47 29 9037440 1:CAS:528:DyaK2sXptlCmtA%3D%3D
29. RP Mason MF Walter CA Day RF Jacob 2005 Intermolecular differences of 3-Hydroxy-3-Methylglutaryl coenzyme: a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions Am J Cardiol 96 suppl 11 10.1016/j.amjcard.2005.06.008 (Pubitemid 41207729)
30. Y Masubuchi 2006 Metabolic and non metabolic factors determining troglitazone hepatotoxicity: A review Drug Metab Pharmakokinet 21 347 10.2133/dmpk.21.347 1:CAS:528:DC%2BD28XhtlWnsr7O
31. G Minniti R Muni G Lanzetta P Marchetti RM Enrici 2009 Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents Anticancer Res 29 5171 20044633 1:CAS:528:DC%2BC3cXht1Kjsrs%3D
32. MK Nicholas 2007 Glioblastoma multiforme: evidence-based approach to therapy Expert Rev Anticancer Ther 7 12 Suppl S23 18076314 10.1586/14737140.7. 12s.S23 1:CAS:528:DC%2BD2sXhsVWgs7zJ
33. S Obara M Nakata H Takeshima J Kuratsu I Maruyama I Kitajima 2002 Inhibition of migration of human glioblastoma cells by cerivastatin in association with focal adhesion kinase (FAK) Cancer Lett 185 153 12169389 10.1016/S0304-3835(02)00278-1 1:CAS:528:DC%2BD38XmtVWnu7g%3D
34. SS Palakurthi H Aktas LM Grubissich RM Mortensen JA Halperin 2001 Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediated by inhibition of translation initiation Cancer Res 61 6213 11507074 1:CAS:528: DC%2BD3MXmt12ktbY%3D
35. A Papi L Tatenhorst D Terwel M Hermes MP Kummer M Orlandi MT Heneka 2009 PPAR gamma and RXR gamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models Neurochem 109 1779 10.1111/j.1471-4159.2009.06111.x 1:CAS:528:DC%2BD1MXnvVeku7c%3D
36. JM Pérez-Ortiz P Tranque M Burgos CF Vaquero J Llopis 2007 Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: modulation of cytotoxicity by nitric oxide Mol Pharmacol 72 407 17504946 10.1124/mol.106.032458 (Pubitemid 47124121)
37. U Pichlmeier A Bink G Schakert W Stummer 2008 The ALA glioma study group resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients Neuro Oncol 10 1025 18667747 10.1215/15228517-2008-052
38. P Prasanna A Thibault L Liu D Samid 1996 Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells J Neurochem 66 710 8592143 10.1046/j.1471-4159.1996.66020710.x 1:CAS:528:DyaK28XnsFCrsQ%3D%3D
39. K Schultze B Böck A Eckert L Oevermann D Ramacher O Wiestler W Roth 2006 Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin Apoptosis 11 1503 16820965 10.1007/s10495-006-8896-3 1:CAS:528:DC%2BD28Xot12jtbw%3D (Pubitemid 44253668)
40. L Sironi E Gianazza P Gelosa U Guerrini E Nobili A Gianella B Cremonesi R Paoletti E Tremoli 2005 Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects Arterioscler Thromb Vasc Biol 25 598 15681303 10.1161/01.ATV.0000157145.98200.55 1:CAS:528:DC%2BD2MXhtl2ku7s%3D (Pubitemid 40315684)
41. MR Soma R Baetta S Bergamaschi MR De Renzis C Davegna F Battaini R Fumagalli S Govoni 1994 PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment Biochem Biophys Res Commun 200 1143 8179595 10.1006/bbrc.1994.1570 1:CAS:528:DyaK2cXivV2lsL4%3D
42. MR Soma R Baetta MR De Renzis G Azzini C Davegna G Butti S Pezzotta G Azzini R Paoletti R Fumagalli 1995 In vivo enhanced antitumor activity of carmustine [N, N′-bis(2-chloroethyl)-N-nitrosourea] by simvastatin Cancer Res 55 597 7834630 1:CAS:528:DyaK2MXjtlyktLo%3D
43. MR Soma P Pagliarini G Butti R Paoletti P Paoletti R Fumagalli 1992 Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N, N′-bis(2-chloroethyl)-N-nitrosourea and beta-interferon on human glioma cells Cancer Res 52 4348 1643632 1:CAS:528:DyaK38XmtVCmtb0%3D
44. A Spagnolo RP Glick H Lin EP Cohen DL Feinstein T Lichtor 2007 Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts J Neurosurg 106 299 17410715 10.3171/jns.2007.106.2.299 1:CAS:528:DC%2BD2sXitVCktL8%3D
45. A Spagnolo EN Grant R Glick T Lichtor DL Feinstein 2007 Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes Neurosci Lett 417 72 17324516 10.1016/j.neulet.2007.02.036 1:CAS:528:DC%2BD2sXjvFGqu7c%3D (Pubitemid 46517843)
46. HK Takahashi G Weitz-Schmidt H Iwagaki T Yoshino N Tanaka M Nishibori 2006 Hypothesis: the antitumor activities of statins may be mediated by IL-18 J Leukoc Biol 80 215 16735695 10.1189/jlb.0406245 1:CAS:528:DC%2BD28Xot1Ons7g%3D (Pubitemid 44835493)
47. A Thibault D Samid AC Tompkins WD Figg MR Cooper RJ Hohl J Trepel B Liang N Patronas DJ Venzon E Reed CE Myers 1996 Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer Clin Cancer Res 2 483 9816194 1:CAS:528:DyaK28XitVymu7o%3D
48. M Yano T Matsumura T Senokuchi N Ishii Y Murata K Taketa, et al. 2007 Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages Circ Res 100 1442 17463321 10.1161/01.RES.0000268411.49545.9c 1:CAS:528:DC%2BD2sXltl2ntr4%3D (Pubitemid 46834756)
49. CJ Yao GM Lai CF Chan AL Cheng YY Yang SE Chuang 2006 Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone Int J Cancer 118 773 16094629 10.1002/ijc.21361 1:CAS:528:DC%2BD28XjvFOqug%3D%3D (Pubitemid 43076030)
50. A Zacco J Togo K Spence A Ellis D Lloyd S Furlong T Piser 2003 3-Hydroxy-3-Methyilglutaryl coenzyme. a reductase inhibitors protect cortical neurons from excitotoxicity J Neurosci 23 1104
51. T Zander JA Kraus C Grommes U Schlegel D Feinstein T Klockgether, et al. 2002 Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPAR gamma J Neurochem 81 1052 12065618 10.1046/j.1471-4159.2002.00899. x 1:CAS:528:DC%2BD38XksV2hs7o%3D (Pubitemid 34809288)
52. SR Bababeygy NV Polevaya S Youssef A Sun A Xiong T Prugpichailers A Veeravagu LC Hou L Steinman V Tse 2009 HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model Anticancer Res 29 4901 20044596 1:CAS:528:DC%2BC3cXht1Gqtb4%3D